Home

Team AGADE is winner of Switch2Product Innovation Challenge
Awards were conferred on the 14 winning ideas of Switch2Product, the Innovation Challenge born with the aim of valorising
“ROBOTS: WITH, WITHIN AND AMONG US”
MAKER FAIRE ROME CONFERENCES 2018



“Robots: with, within and among us” organizzata da Bruno Siciliano, esperto e interprete delle necessità più vitali della
RETRAINER project presented at ICNR2018, Pisa 16th-20th October 2018
RETRAINER EU project will be exhibitor at the International Conference on NeuroRehabilitation and International Symposium on Wearable
Milano, 22 luglio 2018 – Un dispositivo per aiutare chi ha disabilità neuromotorie alla mano ad afferrare e sollevare gli oggetti: a firmare l’invenzione Alessandra Pedrocchi, professoressa del dipartimento
“Bioengineering, a crucial sector for technological development, linked to health and quality of life”
The Sixth National Congress of Bioengineering is the melting pot among biomedical research and clinical
Nearlab-NES is going to be testimonial of “IO PER LEI”,  a Telethon-Foundation-UILDM campaign. We are pleased to invite you to buy the delicious cookies in the main Italian squares to contribute to finance
On 15th May, 2018 at 5 p.m will be presented the previously approved curricula of Master of Science in Biomedical Engineering: Biomechanics e Biomaterials (BBB)

Engineering for Cells, Tissues, Biotechnologies
The students of the Politecnico di Milano put themselves at the service onon-profit societies for social inclusion and disability.
As part of the PEoPLe @ DEIB initiative, three project ideas have been
XXXVII Annual School of Bioengineering – Biomedical images: new tendencies in technology, methods and applications 
will be held from 10 to 13 September in Bressanone, Italy. (Kindly please see the attached
We are proud to announce that Dr. Elena De Momi was interviewed by an Italian national television, Rai, on EDEN2020 project. Congratulations Elena !

This site uses cookies to enhance your experience. By continuing to the site you accept their use. More info in our cookies policy.     ACCEPT